Youthful systemic milieu in young recipients decreased apoptosis and oxidative stress damage in allografts, and promoted proliferation. حسب Chengjun Yu (12136227)

The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. حسب Gui Araujo (22170819)

"…Parameter values: interaction strengths were drawn from a half-normal distribution of zero mean and a standard deviation of 0.2, and strength for consumers was made no larger than the strength for resources. …"

Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

Toxoplasma infection leads to a decrease in the concentration of EVs. حسب Emily Z. Tabaie (16630841)

MAP3K1, MAPK11, and PPP2R1A knockdown decreased ECM internalisation. حسب Montserrat Llanses Martinez (17797522)

Tetrandrine decreases Mtb antigen presentation. حسب Elham Karamooz (2584474)

Lymphocytes decreased in mouse pneumonia model. حسب Qi Xu (134661)

Bacterial abundance in L2 larvae collected from larval flasks inoculated with decreasing quantities of glycerol stock (bacteria source). حسب Margaret V. Becker (21387776)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

PDRN decreases the expression of cellular aging markers. حسب Jingjing Chen (293564)

Submandibular gland removal decreases avoidance of bitter taste in mice حسب Masataka Narukawa (20599511)

Wnt signaling decreases the recruitment of RAB8a to basal bodies. حسب Cheng Yuan (160315)

Decreased spindle microtubules in CAMSAP2 KO cells. حسب Naoko Nishizawa (20536299)

Loss of MAP4K4 expression causes a decrease in the number of neutrophils. حسب Guihua Wang (286390)

Supplementary data for "Submandibular gland removal decreases avoidance of bitter taste in mice" حسب Masataka Narukawa (20599511)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Long-term anti-nucleocapsid response by baseline patient characteristics. حسب Elizabeth S. Munroe (21568166)

الموضوعات: